๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Recurrence risks for trisomies 13, 18, and 21

โœ Scribed by Elizabeth De Souza; Jane Halliday; Annabelle Chan; Carol Bower; Joan K. Morris


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
96 KB
Volume
149A
Category
Article
ISSN
1552-4825

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Trisomy 21 mosaicism in gonads with unex
โœ Sachs, E. S. ;Jahoda, M. G. J. ;Los, F. J. ;Pijpers, L. ;Wladimiroff, J. W. ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 259 KB

The recurrence risk for Down syndrome (DS) is about 1% in case of a previous offspring with trisomy 21 and minimal in case of a de novo (21;21) translocation. We have monitored 1,211 pregnancies in the first and second trimester after a prior occurrence of trisomy 21. Six couples had a trisomy 21 fe

Screening for trisomies 21 and 18 with m
โœ C. Moroz; R. Maymon; E. Jauniaux; L. Traub; H. Cuckle ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB

A component of placental isoferritin, p43, is an immuno-regulatory protein associated with suppression of the immune system. Maternal serum p43 levels increase throughout pregnancy and low serum levels have been associated with various pathological pregnancies, particularly those with a defect of pl